⌕
Kiniksa Pharmaceuticals International · KNSA · Nasdaq
Tenet 55 · Mixed
Compare
$95.11+0.93%At closeTenet 55 · Mixed
$95.11+0.88 (+0.93%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Kiniksa Pharmaceuticals International (KNSA) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice

9 figures withheld by our checks. Each blank figure names its reason.

18
VALUE
High multiples vs sector
premium price vs peers
70
QUALITY
Decent
mid-pack profitability
74
HEALTH
Sturdy
conservative balance sheet
60
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

A decent business at high multiples for its sector: value 18, quality 70, health 74, growth 60, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
18th pctilepremium price vs peers
Earnings yield (EBIT/EV)EBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.1.9%19th pctileown record too shortTTM through Sep 30, 2026
P/E73.014th pctileown record too shortTTM through Sep 30, 2026 · as of close, Nov 16, 2026
P/B10.416th pctileSep 30, 2026 balance sheet
P/FCF37.530th pctileown record too shortTTM through Sep 30, 2026
EV / EBITDA51.610th pctileown record too shortTTM through Sep 30, 2026 · as of close, Nov 16, 2026
74th pctileconservative balance sheet
Current ratio3.9158th pctileSep 30, 2026 balance sheet
Quick ratio(Cash, short-term investments and receivables) ÷ current liabilities, as the data vendor builds it. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.3.1257th pctileSep 30, 2026 balance sheet
Net debt / EBITDADebt less cash and all investments, including long-term stakes, over EBITDA, as the data vendor builds it−4.3×94th pctileown record too shortTTM through Sep 30, 2026
Interest coverage—Not measured: there is no interest expense on file.
Debt / equity0.0086th pctileSep 30, 2026 balance sheet
70th pctilemid-pack profitability
ROIC14%82nd pctileTTM through Sep 30, 2026
ROE18%78th pctileTTM through Sep 30, 2026
Gross margin54.3%33rd pctileTTM through Sep 30, 2026
Net margin11.6%74th pctileown record too shortTTM through Sep 30, 2026
Income quality (CFO/NI)1.81×64th pctileown record too shortTTM through Sep 30, 2026
Piotroski F6 / 970th pctileown record too shortFiscal year to Sep 30, 2026
Altman Z17.891st pctileTTM through Sep 30, 2026
60th pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin20.8%82nd pctileown record too shortTTM through Sep 30, 2026
the receipts behind the numbers above
Greenblatt earnings yield1.9%EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC14%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage— Guarded, not faked: we have no interest-expense figure on file for this company, so it's excluded from the ranking instead of rendered as garbage.
Percentiles computed nightly against 340 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 16, 2026 · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.